Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.53 -0.09 (-2.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Non Operating Investment Income (2025 - 2026)

Updated

Lexeo Therapeutics (LXEO) posted Non Operating Investment Income of -$156,000 for Q2 2026, compared with $41,000 a year earlier.

Analysis

Lexeo Therapeutics (LXEO) Non Operating Investment Income (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Investment Income at Lexeo Therapeutics was -$396,000; for FY2025, it was $291,000.

  • In prior years, Lexeo Therapeutics' Non Operating Investment Income was -$103,000 in FY2024.
  • Quarterly Non Operating Investment Income has run from a low of -$330,000 in Q1 2026 to a high of $49,000 in Q1 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lexeo Therapeutics 277.54 Mn 277.54 Mn - -156,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -156,000.00
Mar 31, 2026 -330,000.00
Jun 30, 2025 41,000.00
Mar 31, 2025 49,000.00
API Access

Lexeo Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LXEO&period=max&api_key=YOUR_API_KEY